Best Biopharma Outsourcing Companies in Capital Region of Denmark, Denmark
The 30 best Biopharma Outsourcing companies in Capital Region of Denmark, Denmark in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Abacus Medicine.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Capital Region of Denmark
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Abacus Medicine Consulting services for market access, health economics and outcomes research | $58M | 76 mo ago | Series A | John Wagner Co-Founder | 2004 | WordPressApple iCloud MailMicrosoft 365+14 | — | — |
| 2 | Freya CRO focused on clinical development services reproductive health | $38M | 24 mo ago | Series A | Johan Van Hylckama Vlieg CSO and co-founder | 2023 | — | — | — |
| 3 | Enduro CDMO focused on manufacturing of microbial strains | $12M | 21 mo ago | Series A | Peter Rugbjerg Co-Founder & CEO | 2019 | — | — | — |
| 4 | Chr. Olesen Distributor of ingredients to the livestock, food, and pharma industries | $11M | 133 mo ago | Series A | Mads Christian Olesen CEO | 1885 | WordPress Block EditorwpBakeryWordPress+24 | — | — |
| 5 | InsuSense CRO focused on drug discovery and development for diabetes and other metabolic diseases | $2M | 133 mo ago | Seed | — | 2011 | — | — | — |
| 6 | Nordic Bioscience Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform | — | 68 mo ago | Late Stage | Morten Asser Karsdal CEO | 1996 | WordPress Block EditorWordPressMySQL+29 | 415 patents Biomarker immunoassays for collagen fragment detection and protease activity monitoring. | — |
| 7 | Bioneer Contract development and manufacturing organization offering services for small molecules & biologics | — | 87 mo ago | Funding Raised | Lars Hagsholm Pedersen CEO | 2003 | WordPressMySQLPHP+24 | 69 patents Innovative syringe designs and targeted liposomal drug delivery systems for pharmaceuticals. | — |
| 8 | BASE Provider of regulatory affairs, digital marketing, and other services | — | 95 mo ago | Acquired | — | 2007 | WordPressApple iCloud MailMySQL+35 | — | — |
| 9 | Biomediq Provider of biomedical image quantification and contract research services | — | 122 mo ago | Acquired | Mads Nielsen Co-Founder & CEO | 2007 | — | 8 patents AI-driven bias correction and biomarker extraction for medical imaging analysis | — |
Top 10 Biopharma Outsourcing companies in Capital Region of Denmark
#1
Series A · Copenhagen, Capital Region of Denmark · founded 2019 · 13 employees$12.4Mraised▾
CDMO focused on manufacturing of microbial strains
- Feb 2025Series A$12.4M
- Apr 2022Seed—
#2
Series A · Copenhagen, Capital Region of Denmark · founded 2023 · 7 employees$38Mraised▾
CRO focused on clinical development services reproductive health
- Nov 2024Series A$11.8M
- Dec 2023Series A$38M
#3
Series A · Copenhagen, Capital Region of Denmark · founded 2004 · 1052 employees$57.6Mraised▾
Abacus Medicine offers consulting services for market access, health economics, and outcomes research. They provide services for strategic business development and support, quality and compliance, cGMP, clinical monitoring, health economic evaluations, and pharmaceutical sales.
#4
Series A · Gentofte, Capital Region of Denmark · founded 1885 · 54 employees$11.3Mraised▾
We welcome you to Chr. Olesen. A family owned company established in 1885 in Denmark.           We have decades of experience in distributing ingredients to the Feed, Food and Pharma industries all over the world.Being a global company has not only taught us to focus on supplying the best products, but also to focus on delivering a dedicated and sincere service all around. From product quality and safety, with a knowledge of prices according to market conditions and trends - to efficient storage, a global delivery service and timely transportation.
#5
Seed · Copenhagen, Capital Region of Denmark · founded 2011 · 1 employees$2.3Mraised▾
Operator of a biotechnology company intended to provide treatment for diabetes and other metabolic diseases such as obesity. The company helps to control sugar levels in the body and has the potential to treat diabetes, enabling patients to begin their treatment more quickly and resulting in a higher likelihood of successful treatment.
- Oct 2015Seed$2.3M
#6
Late Stage · Herlev, Capital Region of Denmark · founded 1996 · 336 employees—raised▾
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
#7
Funding Raised · Copenhagen, Capital Region of Denmark · founded 2003 · 91 employees—raised▾
Bioneer is a business unit located at Department of Pharmacy, the University of Copenhagen which has two divisions include Bioneer FARMA and Bioneer Danish. The company provides services include pre-formulation & formulation service of both biological and small molecules, recombinant protein production using a bacterial and mammalian expression. In addition, the company also offers service such as Nucleic Acids Detection & in situ Hybridization (ISH) to detect RNA & DNA from a sample. The company have also developed in-vitro human disease models.
#8
Acquired · Lyngby, Capital Region of Denmark · founded 2007 · 185 employees$870Kraised▾
Provider of regulatory affairs, digital marketing, and other services
#9
Acquired · Dragor, Capital Region of Denmark · founded 2007—raised▾
Provider of biomedical image quantification and contract research services
#10
Acquired · Copenhagen, Capital Region of Denmark · founded 2001 · 1264 employees—raised▾
CMC Biologics provides biopharmaceutical contract manufacturing services. It offers microbial fermentation and mammalian cell culture based cGMP manufacturing services, such as process development and scale-up of protein processes; and production of biopharmaceuticals for pre-clinical, clinical trials, and market supply. CMC Biologics claims to be one of the few CDMOs that are capable of offering mammalian perfusion production services which include BioSEP, ATF and other perfusion technologies. CMC Biologics also has a proprietary CHEF1® Expression Platform for quicker and effective development through mammalian cell lines. The company also provides consultancy in facility design, quality, and regulatory issues; technology evaluation, analytical development and quality control services. The company has FDA & MHRA approved manufacturing facilities (with both single-use and stainless steel bioreactors) in Copenhagen, Seattle and Berkeley and claims to have completed 120 + projects right from preclinical supply to commercial production. The company was acquired by Japan's AGC Asahi Glass in December 2016.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising